Keytruda Rules The Roost But Merck & Co. Highlights Progress In Other Areas

Keytruda Rules The Roost, But Merck & Co. Highlights Progress In Other Areas

12:39 EDT 20 Jun 2019 | SCRIP

Merck & Co. outlined its near-term growth drivers during an investor day, including Keytruda in breast and prostate cancer, as...